Celltrion Inc is a Korea-based company principally engaged in the research, development, and manufacture of therapeutic proteins. The company mainly manufactures biosimilar products, which are used to treat breast cancer, rheumatoid arthritis disease, Crohn's disease, Hodgkin's lymphoma, colorectal cancer, rheumatoid arthritis, respiratory syncytial virus, colon cancer, and others.

Research Development Foundation is an American private company that operates as noncommercial research organizations.

Medestea Research & Production Spa is a private company headquartered in Italy. The firm manufactures drugs and biotechnological products.

The United States Army Medical Research Institute of Infectious Diseases (USAMRIID; pronounced: you-SAM-rid) is the U.S Army's main institution and facility for defensive research into countermeasures against biological warfare. It is located on Fort Detrick, Maryland and is a subordinate lab of the U.S. Army Medical Research and Materiel Command (USAMRMC), headquartered on the same installation.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Cisen Pharmaceutical Ltd. engages in the manufacturing of comprehensive chemical and pharmaceutical products. It sells liver, antitumor & auxiliary, nutrition, cardiovascular, antibiotics, sedation anesthesia snooze, digestive system, cough & asthma class, immunomodulator, basic infusion, therapeutic infusion, polypropylene ampoules disease drugs. The company key products include Dirithromycin Enteric-coated Capsules, Voglibose Capsules, Cycloclenbuterol Hydrochloride Tablets, Pantoprazole Sodium Enteric-Coated Tablets, Dexmedetomidine Hydrochloride, Sodium Chloride, Iohexol, Oxaliplatin & Mannitol Injection, Adefovir Dipivoxil Tablets, Glycerol Fructose & Sodium Chloride Injection and other related drugs. Cisen Pharmaceutical was founded on November 6, 1998 and is headquartered in Jining, China.

Golden Rich Intellectual Property Consulting (Shenzhen) Co., Ltd., established on 2013-05-23, Business scope includes general business items:Intellectual Property Consulting Services(Involving license management or requiring relevant qualifications to operate,According to relevant regulations).,The licensing program is:

Opteev is a health safety technology that emphasizes sophisticated biosensor research and life-saving technology development. Opteev is helping to make the world a safer place by delivering early warning systems for COVID-19 and other hazardous respiratory viruses.

Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

Shanghai Jiatan Pharmaceutical Technology Co., Ltd., established on 2016-11-18, Business scope includes technology development in the field of medical science and technology,Technical Services,technology transfer,technical consulting,Packaging Materials,one type,Class II medical device,Laboratory equipment and consumables,Biological reagents for non-clinical diagnosis,Edible produce,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals),cosmetic,Instrumentation,Research and development of electronic products,Sales,drug development,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Part of Founders Combined Charity Income Common Investment Fund, Fondazione Telethon is an Italian company located in Rome that operates as a healthcare charity.\nThe company says this about itself: Fondazione Telethon is a non-profit organisation created in 1990 as a response to the appeals of a patient association group of stakeholders, who saw scientific research as the only real opportunity to effectively fight genetic diseases. Thanks to the funds raised through the television marathon, along with other initiatives and a network of partners and volunteers, Telethon finances the best scientific research on rare genetic diseases, evaluated and selected by independent internationally renowned experts, with the ultimate objective of making the treatments developed available to everyone who needs them. Throughout its 30 years of activity, Fondazione Telethon has invested more than �� 528 million in funding more than 2.630 projects to study more than 570 diseases, involving over 1.600 scientists. Fondazione Telethon has made a significant contribution to the worldwide advancement of knowledge regarding rare genetic diseases and of academic research and drug development with a view to developing treatments.

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

Nanjing Mingde New Drug Research and Development Co., Ltd., established on 2011-12-16, The scope of business includes engaging in pharmaceutical,Biological product,medical instruments,food development,Research;Environmental and pesticide testing services;Pharmaceutical Small Molecule Compound Library,Preclinical studies of drug leads and drug products,Technology development related to process development and clinical research,Technology introduction,Technical Services,Technical consulting and technology transfer,related technology,Licensing of Patents and Intellectual Property,Achievement Transformation and Transfer;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval)

Beihai Lvdi Biotechnology Co., Ltd., established on 2013-10-21, The scope of business includes research on new technologies for water quality treatment,to promote,introduce,transfer,consultation service;bio organic fertilizer,Study on Microbial Substrate Water Quality Improver,Production,Sales;Feed additives,feed,Electric vehicle battery,bottled wine,Sales of environmental protection equipment;Environmental Protection Monitoring,Ecological Survey and Monitoring,Environmental Impact Assessment,Construction project completion environmental protection acceptance investigation and monitoring,Environmental Engineering,Ocean engineering,Environmental supervision,Engineering Management,energy saving,Cleaner Production Technical Consulting,Technical Services;Sea Area Use Argument,Preparation of Soil and Water Conservation Program for Development and Construction Projects*(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Critical Diagnostics is a company on the cutting edge of this change, focused on the discovery, development, and commercialization of novel biomarkers in cardiovascular diseases. Their lead product, the Presage® ST2 Assay, has received FDA clearance and is CE Marked in Europe. This simple, non-invasive test measures for soluble ST2 in the blood, which can aid physicians in risk assessment of heart failure patients. Soluble ST2 has now been published in more than 100 peer-reviewed articles and scientific posters studying more than 36,000 patients. These clinical studies have demonstrated that high levels of soluble ST2 are predictive of adverse patient outcomes and death in a broad spectrum of cardiovascular disease. They have further shown that the prognostic information from soluble ST2 is independent and provides added information to the cardiac biomarkers commonly used today, including the natriuretic peptides, BNP and NT-proBNP. Critical Diagnostics was founded in 2004. The Company licensed intellectual property discovered in 2002 at Brigham and Women's Hospital relating to ST2, for which it now holds the exclusive worldwide rights. The company has since expanded its intellectual property portfolio and holds several issued patents in the US and abroad as well as numerous patents pending.